Particularly, GD3 expressed on melanoma is known to activate both CD4+CD8− NKT and CD4−CD8− NKT cells to produce IL-4 [90], whereas CD4− CD8− NKT cells also react with GM3 as a tumor-associated suppressive glycolipid in a CD1d-restricted manner [91]. This evidence concerns the gene CD4 and melanoma.